State-of-the-art infrastructure to speed up protein analysis in Catalonia
July 2021.- The Proteomics Unit of the Centre for Genomic Regulation (CRG) and universitat Pompeu Fabra (UPF) -part of OmicsTech- has teamed up with several leading hospitals and research institutes in Catalonia to create a new state-of-the-art infrastructure for the study and analysis of proteins. It is the first collaboration between biomedical research institutes and hospitals of its kind. The newly acquired high-tech equipment will help meet the increasing demand for protein analysis by Catalan research and innovation institutions.
In recent years, technological advances have led to a wide range of new proteomics and protein analysis techniques that are a key tool for understanding the mechanism of action of human diseases.
According to Eduard Sabidó, Head of the CRG-UPF Proteomics Unit, the new infrastructure will help create new knowledge and enable future exciting discoveries.
“Having shared access to high-level technology will provide new analysis tools for the characterization of proteins in biomedical samples and translational projects, especially in the field of biomedicine and personalized medicine,” he says.
“There are many potential applications for this new equipment. For example, we can use it to study and validate biological markers for the diagnosis or prognosis for various conditions. It can also help us determine how proteins bind to genetic material, evaluate the molecular effects of pharmacological treatments, or deduce how cancer signalling works inside cells. The new equipment will also facilitate the characterization of protein-protein interactions, and the quantification of proteins in paraffin-embedded tissues, liquid biopsies, and tissues.”
The infrastructure is co-funded by the participating institutes, ‘la Caixa’ Foundation, and the European Union’s Regional Development Funds, managed by the Secretary of Universities and Research of the Catalan Government.
The equipment will be physically located at the Proteomics Unit, located at the Barcelona Biomedical Research Park (PRBB) which is nationally recognised research infrastructure of excellence in Spain and further afield.
The seven institutions that form part of the infrastructure are:
- Centre for Genomic Regulation (CRG)
- Vall d’Hebron Oncology Research Institute (VHIO)
- Bellvitge Biomedical Research Institute (IDIBELL)
- Germans Trias i Pujol Health Sciences Research Institute (IGTP)
- University of Barcelona (UB) / Barcelona Science Park (PCB)
- Sant Joan de Déu Foundation (FSJD)
- Santa Creu i Sant Pau Hospital Research Institute Foundation (FIRHSCSP)
Title: CRG-ProMed - Creació i desenvolupament de la Plataforma de Proteòmica Biomèdica (Unitat CRG) per aplicacions biomèdiques i translacionals
Objective: Strenghtening of R+D institutions and setting up, consolidation and improvement of scientific and technological infrastructures
OT1. Boost research, technological development and innovation (Potenciar la investigació, el desenvolupament tecnològic i la innovació)
Project Nr.: IU16-015644
Eligible total cost: 1.186.000 €
ERDF funds: 593.000 €
Period: 01/01/2019 to 30/06/2021
This project is co-financed by the European Regional Development Funds of the European Union, in the framework of the ERDF Operative Programme of Catalonia 2014-2020.